Lomond Therapeutics Holdings, Inc. Quarterly Liabilities, Current in USD from Q4 2022 to Q4 2024

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Lomond Therapeutics Holdings, Inc. quarterly Liabilities, Current history and growth rate from Q4 2022 to Q4 2024.
Lomond Therapeutics Holdings, Inc. Liabilities, Current for the quarter ending December 31, 2024 was $2.55M, a 198% increase year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2024	$2.55M	+$1.7M	+198%	Dec 31, 2024	10-K	2025-04-15
Q3 2024	$138K	+$45.1K	+48.4%	Sep 30, 2024	10-Q	2024-10-28
Q2 2024	$128K	+$45.1K	+54.3%	Jun 30, 2024	10-Q	2024-08-13
Q1 2024	$129K			Mar 31, 2024	10-Q	2024-05-14
Q4 2023	$856K	+$802K	+1474%	Dec 31, 2023	10-K	2025-04-15
Q3 2023	$93.1K			Sep 30, 2023	10-Q	2023-11-13
Q2 2023	$83.1K			Jun 30, 2023	10-Q	2023-08-10
Q4 2022	$54.4K			Dec 31, 2022	10-K	2024-04-01

* An asterisk sign (*) next to the value indicates that the value is likely invalid.